MedPath

A Comparative study of different dosing regimens in children with irondeficiency anemia

Not Applicable
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Registration Number
CTRI/2023/01/048846
Lead Sponsor
Amith k
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children aged 6 months to 18 years with untreated or newly diagnosed IDA.

Mild to moderate anemia

Exclusion Criteria

Clinically on the basis of hemogram other causes of anemia apart from IDA.

Children with severe anemia.

Children on hematinics supplementing with past 3 months of recruitments.

Children with poor compliance from both arms.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement in complete blood count parameter ,mainly rise in hemoglobin after initiation of iron therapy in both daily regime and alternate day regimeTimepoint: Complete blood count is done at end of 4th week and 8 week to check rise in hemoglobin and other blood indices in both daily and alternate day regimen. iron therapy will be continued for 3 months as per the treatment protocol
Secondary Outcome Measures
NameTimeMethod
to study gastrointestinal side effect by recall methodTimepoint: at the end of 4th week after the onset of treatment
© Copyright 2025. All Rights Reserved by MedPath